Stay Informed. Stay Competitive with FREE Insights on the Stock Market, Dow 30 & Emerging Opportunities. Get Free Email Updates

Stay Competitive With Stock Market Updates!

Get Free Updates

FOX NEWS INTERVIEW TODAY: “Atossa Therapeutics'(ATOS) CEO Steven Quay MD, PhD Regarding New COVID-19 Hope Trial”

By John F. Heerdink, Jr.

Steven Quay M.D., Ph.D. is the founder, Chairman & CEO of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions. He received his M.D. and Ph.D. from The University of Michigan was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine.

His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Today, Dr. Quay was interviewed by Fox News regarding his COVID-19 Hope Trial where he is seeking to study the use of two approved drugs to rapidly find a viable coronavirus treatment.

Here’s the link to the interview in case you missed it earlier today:

Post View Count : 652


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us